Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TT32XQJ)

• DTT Name: Monoamine oxidase (MAO) DTT Info
• Gene Name: MAO

Molecule-Related Drug & Molecule List

8 Approved Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Clorgyline	DMCEUJD	Parkinson disease	8A00.0	Approved	[1]
Ergoloid mesylate	DMORPBA	Alzheimer disease	8A20	Approved	[2]
Methylene blue	DMJAPE7	Acquired methemoglobinemia	3A93	Approved	[3]
Moclobemide	DMNZWL7	Depression	6A70-6A7Z	Approved	[1]
Pargyline	DMM0HR1	Hypertension	BA00-BA04	Approved	[1]
Phenelzine	DMHIDUE	Depression	6A70-6A7Z	Approved	[1]
Selegiline	DM6034S	Major depressive disorder	6A70.3	Approved	[1]
Tranylcypromine	DMGB5RE	Major depressive disorder	6A70.3	Approved	[1]

10 Patented Agent(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
(-)-deprenyl	DMMLQAS	Alopecia	ED70	Patented	[1]
Cyclopropylamine derivative 10	DMZ5WN8	N. A.	N. A.	Patented	[4]
Cyclopropylamine derivative 11	DMMJ0YN	N. A.	N. A.	Patented	[4]
Cyclopropylamine derivative 12	DMV4I0K	N. A.	N. A.	Patented	[4]
Cyclopropylamine derivative 13	DMXNVD4	N. A.	N. A.	Patented	[4]
Cyclopropylamine derivative 9	DMX7YAL	N. A.	N. A.	Patented	[4]
Lazabemide	DMCULK7	Skin imperfections	EK71	Patented	[1]
N-(2-phenylcyclopropyl) amino acid derivative 2	DM6YV3O	N. A.	N. A.	Patented	[4]
PMID27019002-Compound-17	DM7JASU	N. A.	N. A.	Patented	[4]
PMID27019002-Compound-20a	DMRX748	N. A.	N. A.	Patented	[4]

References

• [1] Novel monoamine oxidase inhibitors: a patent review (2012 - 2014).Expert Opin Ther Pat. 2015 Jan;25(1):91-110.
• [2] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
• [3] Photoluminescence of CdTe nanocrystals modulated by methylene blue and DNA. A label-free luminescent signaling nanohybrid platform. Phys Chem Chem Phys. 2009 Jul 7;11(25):5062-9.
• [4] LSD1 inhibitors: a patent review (2010-2015).Expert Opin Ther Pat. 2016 May;26(5):565-80.